Fatal acute splenic sequestration crisis in an adult patient with sickle cell-beta+ thalassaemia is described. To our knowledge fatal splenic sequestration in adult sickle cell-beta thalassaemia has not been previously reported.
Introduction
Sickle cell-beta thalassaemia is a heterogeneous disorder with a variable clinical expression ranging from a symptomless state to a condition indistinguishable from homozygous sickle cell anaemia. Sickle cell-beta' thalassaemia is generally thought to represent the milder end ofthe spectrum ofsickle cell syndromes. We describe an adult case with fatal acute splenic sequestration (ASS) illustrating that sickle cell-beta thalassaemia may run an unexpected severe clinical course.
Case report
A 32 year old man of Jamaican ancestry was admitted with generalized bone pains. He was known to have sickle cell-beta' thalassaemia for which he had required hospital admission for sickle cell crisis only once previously. Physical The most striking finding at post-mortem was that of marked splenomegaly. The spleen was firm, deeply plum coloured and weighed 750 g (normal 150 g). Microscopy confirmed intense congestion by sickle shaped red blood cells, obscuring the normal structure of the splenic parenchyma ( Figure 1 ). The liver was slightly enlarged at 1800 g (normal 1500 g) and microscopy showed marked sinusoidal congestion. The brain showed hypoxic neuronal loss in many cortical areas due to occlusion of small cerebral vessels by sickled red cells. The bone marrow showed active haemopoiesis with no evidence of aplasia. Extensive red cell sickling in the bone marrow sinusoids was noted. 
Discussion
Sickle cell-beta' thalassaemia is due to the interaction between HbS and the mild Negro form of beta' thalassaemia resulting in a HbA level of 18-30% which has an inhibitory effect on red cell sickling. It runs a milder course than sickle cell anaemia with a lower incidence of anaemia, vasoocclusive episodes and leg ulcers. Nearly half of the patients are asymptomatic and the diagnosis is frequently made incidentally on population screening.' However, it is important to emphasize that serious complications may occur unexpectedly as is shown by our patient, who developed fatal ASS.
ASS is characterized by sequestration ofred cells in the spleen causing anaemia and hypovolaemia with circulatory failure in the presence of a cellular marrow. The marked fall in haemoglobin in this patient may have been aggravated by intravascular haemolysis. Although the reticulocyte count was not elevated, the presence of 17% normoblasts in the peripheral blood indicated an actively responding marrow, whilst bone marrow histology excluded aplastic crisis. Cerebral hypoxia due to intravascular sickling precipitated convulsions.
ASS is most common in children between 6 and 12 months with homozygous sickle-cell anaemia.2 Reports in adults are few, for splenic red cell sequestration can only occur if the spleen. is not fully fibrosed, but still distensible. The presence of splenomegaly in adult patients with sickling disorders is therefore of clinical importance. Splenomegaly in adult homozygous sickle cell anaemia is generally thought to be rare but an incidence of 9% has been described in a Jamaican population.3 Reduction in splenic size with malaria prophylaxis suggests that malaria may contribute to splenomegaly in sickle cell anaemia in endemic areas. 4 Clinical splenomegaly in sickle cell-HbC disease is over 50% in most series. 
